Buffington Mohr McNeal’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$497K Sell
602
-2,087
-78% -$1.74M 0.1% 72
2024
Q4
$2.08M Buy
2,689
+2
+0.1% +$1.66K 0.34% 46
2024
Q3
$2.38M Sell
2,687
-126
-4% -$113K 0.39% 45
2024
Q2
$2.55M Sell
2,813
-152
-5% -$122K 0.45% 44
2024
Q1
$2.31M Sell
2,965
-38
-1% -$27K 0.42% 43
2023
Q4
$1.75M Buy
3,003
+63
+2% +$36.8K 0.35% 46
2023
Q3
$1.58M Sell
2,940
-625
-18% -$322K 0.36% 47
2023
Q2
$1.67M Sell
3,565
-775
-18% -$325K 0.36% 44
2023
Q1
$1.49M Buy
4,340
+110
+3% +$37.1K 0.34% 46
2022
Q4
$1.55M Buy
4,230
+200
+5% +$70.9K 0.36% 46
2022
Q3
$1.3M Buy
4,030
+225
+6% +$71.3K 0.31% 53
2022
Q2
$1.23M Sell
3,805
-245
-6% -$73.5K 0.27% 62
2022
Q1
$1.16M Sell
4,050
-570
-12% -$147K 0.22% 70
2021
Q4
$1.28M Hold
4,620
0.22% 67
2021
Q3
$1.07M Sell
4,620
-650
-12% -$160K 0.2% 70
2021
Q2
$1.21M Sell
5,270
-300
-5% -$60.3K 0.24% 64
2021
Q1
$1.04M Sell
5,570
-575
-9% -$112K 0.22% 67
2020
Q4
$1.04M Buy
6,145
+1,265
+26% +$189K 0.24% 63
2020
Q3
$722K Buy
4,880
+375
+8% +$58K 0.19% 73
2020
Q2
$740K Buy
4,505
+500
+12% +$76.8K 0.21% 74
2020
Q1
$556K Buy
4,005
+1,620
+68% +$223K 0.19% 78
2019
Q4
$313K Hold
2,385
0.09% 101
2019
Q3
$267K Hold
2,385
0.08% 103
2019
Q2
$264K Sell
2,385
-4,340
-65% -$511K 0.08% 107
2019
Q1
$873K Sell
6,725
-155
-2% -$18.8K 0.28% 62
2018
Q4
$796K Buy
6,880
+830
+14% +$92.7K 0.32% 60
2018
Q3
$649K Buy
6,050
+110
+2% +$11K 0.22% 81
2018
Q2
$507K Sell
5,940
-110
-2% -$9.04K 0.19% 87
2018
Q1
$468K Buy
6,050
+1,325
+28% +$107K 0.18% 92
2017
Q4
$399K Hold
4,725
0.15% 97
2017
Q3
$396K Buy
4,725
+175
+4% +$14.4K 0.15% 98
2017
Q2
$374K Buy
+4,550
New +$371K 0.15% 107

Other funds holding LLY

Buffington Mohr McNeal's LLY Position: Q1 2025 in Review

Buffington Mohr McNeal reduced its Eli Lilly (LLY) stake by 78% in Q1 2025, selling an estimated $1.74M and leaving 602 shares worth $497K. The position accounts for 0.1% of the portfolio, ranked #72.

Buffington Mohr McNeal first reported a position in LLY in Q2 2017 and has held it in 32 quarters since. The position peaked at $2.55M in Q2 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Buffington Mohr McNeal held 602 shares of Eli Lilly worth $497K as of Q1 2025.
  • Buffington Mohr McNeal sold 2,087 Eli Lilly shares in Q1 2025, an estimated $1.74M.
  • Eli Lilly made up 0.1% of Buffington Mohr McNeal's portfolio in Q1 2025, its #72 holding.
  • Buffington Mohr McNeal first reported a position in Eli Lilly in Q2 2017 and has held it in 32 quarters since.
  • Buffington Mohr McNeal's Eli Lilly position peaked at $2.55M in Q2 2024.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Buffington Mohr McNeal's 13F filing for Q1 2025, filed 28 Apr 2025.